Transfer marks start of vital development stage as company expands its range of synthesized DNA

Patients living with the debilitating impacts of migraine attacks will be able to access Vydura

Updated Date: Tue, 02 May 2023 00:00:00 EDT

Four years, four culture secretaries, and six gambling ministers after promising to review the 2005 Gambling Act, the […]

Key messagesIn Europe, the number of approvals for new drugs targeting rare diseases (orphan drugs) has risen sharply […]

CMAJ, the journal of the Canadian Medical Association (CMA), is closing its news section and its online open […]

Notice if someone is being excludedFarah Jameel, GP, the Museum Practice, says, “As an international medical graduate (IMG) […]

In 1983 the US Congress enacted the Orphan Drug Act, establishing financial incentives for companies to develop new […]

AbstractObjectiveTo analyze the US Food and Drug Administration (FDA) approval, trials, unmet needs, benefit, and pricing of ultra-rare […]

Heath and Montori’s article on responding to the crisis in modern healthcare reminded me of Robert Lustig’s words: […]